Skip to main content
. Author manuscript; available in PMC: 2022 Nov 17.
Published in final edited form as: Curr Drug Metab. 2020;21(5):390–399. doi: 10.2174/1389200221666200514130441

Table 3.

Estimated model parameters of safety analysis.

AEs Intercept ω2 of
intercept
Slope ω2
Oxycodone Oxymorphone Tramadol Oxycodone Oxymorphone Tramadol
Constipation 5.32 0.0602 0.0470 0.0141 0.00460 0.0000100 0.0000100 0.0000100
Nausea 8.67 0.0501 0.0390 0.0248 0.00395 0.149 0.0137 0.00430
Vomiting 2.67 0.0129 0.0409 0.0305 0.00510 0.111 0.0000100 0.136
Dizziness 5.85 0.0359 0.0351 0.0183 0.00390 0.0515 0.00400 0.0000100
Headache 7.59 0.0787 −0.000100 0.00380 0.000100 0.00570 0.0333 3.01
Somnolence 3.76 0.0846 0.0405 0.0190 0.00431 0.0000100 0.0000100 0.126
Xerostomia 2.47 0.117 0.0229 0.0164 0.0036 0.0000135 0.0000100 0.0000100
Pruritus 2.23 0.0248 0.0475 0.0259 0.00397 0.0000100 0.0000100 0.0000100
Fatigue 2.61 0.00220 0.0260 0.00960 0.00320 0.0788 0.0000100 0.0000100